Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mehul Desai
Cincinnati, Ohio, United Stateschicagobankruptcyattorney.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Enable Injections develops and manufactures the enFuse wearable drug delivery system, enabling hands-free subcutaneous administration of large-volume pharmaceutical and biologic therapeutics. The company has established partnerships with pharmaceutical companies to support clinical development and commercialization of therapies using its platform. Clinical results pertain to usability, safety, and patient experience rather than direct therapeutic efficacy.[4][6][7]
- Modalities
- DeviceBiologicSmall molecule
- Industry
- Therapeutic Medical Devices
02
Partnerships
Apellis Pharma[4][7]
Beyond the preview
Go deeper on Mehul Desai.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mehul Desai.